Adam Rasmussen, MD
Family Medicine · Papillion, NENPI 1467866277
Payments from drug & device makers
Across 194 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$903
- Novo Nordisk$607
- AbbVie$560
- AstraZeneca$289
- Amarin Pharma, Inc.$182
- Amgen$167
- plus $804 from 22 others
What the payments were for
- Food & beverage$3,41397%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 29 | $903 |
| Novo Nordisk | 42 | $607 |
| AbbVie(2 entities) | 34 | $560 |
| AstraZeneca | 14 | $289 |
| Amarin Pharma, Inc. | 11 | $182 |
| Amgen | 11 | $167 |
| Novartis | 10 | $127 |
| Kowa Pharmaceuticals America, Inc. | 5 | $62 |
| Medtronic | 1 | $54 |
| Bristol Myers Squibb | 4 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Lilly USA, LLC | 3 | $41 |
| Antares Pharma, Inc. | 2 | $39 |
| Ironwood Pharmaceuticals, Inc | 3 | $37 |
| Genentech USA, Inc. | 2 | $35 |
| Exact Sciences | 2 | $35 |
| Bayer | 2 | $28 |
| Pfizer | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Promius Pharma LLC | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$3,512 in reported general payments places this provider in the 85th percentile of 981 family medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $20,842 |
| Methocarbamol | 15 | $429 |
| Rosuvastatin Calcium | 24 | $377 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $361 |
| Atorvastatin Calcium | 45 | $348 |
| Pantoprazole Sodium | 37 | $282 |
| Levothyroxine Sodium | 42 | $269 |
| Omeprazole | 11 | $254 |
| Famotidine | 14 | $177 |
| Gabapentin | 12 | $172 |
| Amlodipine Besylate | 19 | $166 |
| Losartan Potassium | 19 | $165 |
| Chlorthalidone | 13 | $158 |
| Cyclobenzaprine Hcl | 12 | $116 |
| Metformin Hcl | 18 | $114 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Papillion
- Lorrie McGillPapillion$1.5M
- Jeffry StrohmyerPapillion$9K
- Sarah HurdPapillion$9K
- Brandon EssinkCreighton$92.8M
- Adam BroszGrand Island$60M
- David EnszSouth Sioux City$33.3M
- Allen HuntLincoln$17.2M
- Thomas WolfFremont$8.2M
- William FitzgibbonsElkhorn$7M
- Kenneth BladOmaha$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.